ConnorEMSperlingRSGelberRKiselevPScottGO'SullivanMJ. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med1994;331:1173–80.
2.
Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Recomm Rep1994;43(RR-11):1–20.
3.
U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Recomm Rep1995;44(RR-7):1–15.
4.
Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. MMWR Recomm Rep1998;47(RR-2):1–30.
BulterysMJamiesonDJO'SullivanMJCohenMHMaupinRNesheimS. Rapid HIV-1 testing during labor: a multicenter study. JAMA2004;292:219–23.
7.
ShafferNChuachoowongRMockPABhadrakomCSiriwasinWYoungNL. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomized controlled trial. Lancet1999;353:773–80.
8.
The PETRA Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (PETRA study): a randomized, double-blind, placebo-controlled trial. Lancet2002;359:1178–86.
9.
GuayLAMusokePFlemingTBagendaDAllenMNakabiitoC. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 Kampala, Uganda: HIVNET 012 randomized trial. Lancet1999;354:795–802.
10.
JacksonJBMusokePFlemingT. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmissions of HIV-1 Kampala, Uganda: 18 month follow-up of the HIVNET 012 randomized trial. Lancet2003;362:859–68.
11.
MoodleyDMoodleyJCoovadiaHGrayGMcIntyreJHofmyerJ. A multicenter randomized trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of HIV-1. J Infect Dis2003;187:725–35.
12.
New Jersey Department of Health and Senior Services. Standard of care for women who present in labor with unknown HIV serostatus. January 2002 [cited 2009 Feb 25]. Available from: URL: http://www.state.nj.us/health/aids/stdcare.pdf
13.
PaulSM. Rapid diagnostic HIV testing. Presented at the UMDNJ Center for Continuing & Outreach Education; 2005 Nov 3; Princeton, New Jersey.
14.
SiaJPaulSMartinRMCrossH. HIV infection and zidovudine use in childbearing women. Pediatrics2004;114:e707–12.
PaulSMPolletCBurrCKBardeguezAKhanlouP. Prevention of perinatal HIV transmission. New Jersey Med2001;983:23–31.
17.
BogartLMHowertonDLangeJBeckerKSetodjiCMAschSM. Scope of rapid HIV testing in urban U.S. hospitals. Public Health Rep2008;123:494–503.
18.
JamiesonDJCohenMHMaupinRNesheimSDannerSPLampeMA. Rapid human immunodeficiency virus-1 testing on labor and delivery in 17 US hospitals: the MIRIAD experience. Am J Obstet Gynecol2007;197(3 Suppl):S72–82.
19.
MargolinFWhitemoreHStangerKPickreignJKangR. Preventing perinatal HIV transmission: barriers to universal hospital testing. Poster presented at the Academy Health Annual Research Meeting; 2005 Jun 26; Boston.
20.
Vovici Corp.Web Surveyor: Version 3.6. Dulles (VA): Vovici Corp.; 2010.
21.
SAS Institute, Inc.SAS®: Version 9.1.3. Cary (NC): SAS Institute, Inc.; 2004.
BransonBMHandsfieldHHLampeMAJanssenRSTaylorAWLyssSB. Revised recommendations of HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep2006;55(RR-14):1–17.
CohenMHOlszewskiYWebberMPBlaneyNGarciaPMaupinR. Women identified with HIV at labor and delivery: testing, disclosing and linking to care challenges. Matern Child Health J2008;12:568–76.
31.
PattersonKBLeonePAFiscusSAKurucJMcCoySIWolfL. Frequent detection of acute HIV infection in pregnant women. AIDS2007;21:2303–8.